Gambling Disorder in the United Kingdom: key research priorities and the urgent need for independent research funding

Accepted/In Press date: 10 August 2021

e-pub ahead of print date: 15 February 2022

Published date: 17 March 2022

Additional Information: HB is the director of the National Problem Gambling clinic and the national centre for gaming disorders. These clinics have received funding from NHS England, CNWL NHS Trust, and GambleAware. HB is the President of the Psychiatry Section at the Royal Society of Medicine and sits on several national and international Boards. HB has been on research teams funded by the Medical Research Council, the Wellcome Trust, and the Wolfson Family Trust. SRC’s role in this paper was funded by a Clinical Fellowship from the Wellcome Trust (reference 110049/Z/15/Z & 110049/Z/15/A). SRC consults for Promentis on work unrelated to the content of this paper. SRC also receives stipends from Elsevier for editorial work at Comprehensive Psychiatry, and at Neuroscience & Biobehavioral Reviews. JEG has received research grants from Biohaven, Promentis, and Otsuka Pharmaceuticals. JEG receives yearly compensation from Springer Publishing for acting as Editor in Chief of the Journal of Gambling Studies and has received royalties from Oxford University Press, American Psychiatric Publishing, Norton Press, and McGraw Hill. SC declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non profit associations: Association for Child and Adolescent Central Health Policywww.thelancet.com/psychiatry Vol 9 April 2022 327 Health, Canadian ADHD Alliance Resource, British Association of Pharmacology, and Healthcare Convention for educational activity on ADHD. OC has received royalties from Routledge, Springer, and Elsevier for editorial duties and advises the UK Parliament and the United Nations on addiction related matters. OC held various research grants from the European Union, World Anti Doping Agency, and University of Hertfordshire. SAT has received royalties from Elsevier and research grants from the National Health and Medical Research Council, Australian Research Council, and the Victorian and Australian Governments. SD has received funding from GambleAware and is the Director of the Gambling Research, Education and Treatment Network Wales, which is funded by the Welsh Government through Health and Care Research Wales. BJS consults for Cambridge Cognition, Greenfield Bioventures, and Cassava Sciences. BJS’s research is funded by Eton College and the Wallitt Foundation, and is conducted within the National Institute for Health Research (NIHR) MedTech and in vitro diagnostic Co operative, and the NIHR Cambridge Biomedical Research Centre Mental Health Theme. In the past 3 years NAF has held research or networking grants from the European College of Neuropsychopharmacology (ECNP), UK NIHR, EU H2020 (COST), Medical Research Council, and University of Hertfordshire. In the past 3 years NAF has accepted travel and hospitality expenses from the British Association for Pharmacology, ECNP, Royal College of Psychiatrists, CINP, International Forum of Mood and Anxiety Disorders, World Psychiatric Association, Indian Association for Biological Psychiatry, and Sun. In the past 3 years NAF has received payment from Taylor and Francis and Elsevier for editorial duties and has accepted paid speaking engagements sponsored by Abbott and Sun. Previously, NAF has accepted paid speaking engagements in symposia supported by various pharmaceutical companies and has recruited patients for various pharmaceutical industry sponsored studies in the field of obsessive compulsive disorder (OCD) treatment. NAF leads an NHS treatment service for OCD and holds Board membership for various registered charities linked to OCD. NAF gives expert advice on psychopharmacology to the UK Medicines and Healthcare products Regulatory Agency. NAD reports research funding from multiple sources, including government departments (through hypothecated taxes from gambling revenue), and is the recipient of a Deakin University Faculty of Health Mid Career Fellowship. TWR consults for Cambridge Cognition, Takeda, Greenfield Bioventures, Cassava, Shionogi, Heptares, Arcadia. TWR reports grants from GlaxoSmithKline, Shionogi Royalties, and Cambridge Cognition; and Editorial Honoraria from Springer Nature and Elsevier. The rest of the authors declared no competing interests. Acknowledgments This research was conducted through the National UK Network for Behavioural Addictions (NUK BA) led by SRC and HB. This publication is based upon work from European Cooperation in Science and Technology (COST) Action CA16207 “European Network for Problematic Usage of the Internet”, supported by COST.

Keywords: disordered gambling, funding, addiction, impulsive, compulsive

Local EPrints ID: 450916

URI: http://eprints.soton.ac.uk/id/eprint/450916

DOI: doi:10.1016/ S2215-0366(21)00356-4

ISSN: 2215-0366

PURE UUID: f1a67f95-36be-4b5c-9942-7640b9b0df7d

ORCID for Samuele Cortese: orcid.org/0000-0001-5877-8075

ORCID for Samuel Chamberlain: orcid.org/0000-0001-7014-8121

Date deposited: 20 Aug 2021 16:37

Last modified: 30 Aug 2024 04:01